We are live on ! Find out more
AC

Apogem Capital Portfolio holdings

AUM $303K
1-Year Est. Return 46.01%
This Fund
S&P 500
This Quarter Est. Return
-3.82%
1 Year Est. Return
-46.01%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$146M
AUM Growth
-$6.11M
Cap. Flow
+$6.8M
Cap. Flow %
4.64%
Top 10 Hldgs %
28.72%
Holding
210
New
36
Increased
52
Reduced
44
Closed
36

Top Buys

Rank Stock Value
1
OEC icon
Orion
OEC
+$3.8M
2
AKTS
Akoustis Technologies Inc
AKTS
+$1.87M
3
VOD icon
Vodafone
VOD
+$1.7M
4
NWG icon
NatWest
NWG
+$1.43M
5
GT icon
Goodyear
GT
+$1.25M

Top Sells

Rank Stock Value
1
FISV
Fiserv Inc
FISV
+$2.19M
2
EZPW icon
Ezcorp Inc
EZPW
+$1.95M
3
ZUO
Zuora, Inc.
ZUO
+$1.48M
4
AON icon
Aon
AON
+$1.18M
5
UPBD icon
Upbound Group
UPBD
+$893K

Sector Composition

Rank Sector Weight
1 Technology 25.53%
2 Industrials 16.72%
3 Consumer Discretionary 15.88%
4 Materials 9.92%
5 Healthcare 8.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MAXR
151
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
$209K 0.14%
5,300
-8,200
-61% -$251K
PSTH
152
DELISTED
Pershing Square Tontine Holdings, Ltd.
PSTH
$209K 0.14%
10,484
NEO icon
153
NeoGenomics
NEO
$2.04B
$202K 0.14%
+16,617
New +$350K
STRL icon
154
Sterling Infrastructure
STRL
$17.8B
$201K 0.14%
7,500
-5,500
-42% -$154K
THR
155
DELISTED
Thermon Group Holdings
THR
$194K 0.13%
+12,000
New +$209K
OSCR icon
156
Oscar Health
OSCR
$9.42B
$174K 0.12%
17,462
-52,034
-75% -$387K
FARM
157
DELISTED
Farmer Brothers
FARM
$157K 0.11%
22,000
LVOX
158
DELISTED
LiveVox Holding, Inc. Class A Common Stock
LVOX
$157K 0.11%
51,852
-17,306
-25% -$76K
VVNT
159
DELISTED
Vivint Smart Home, Inc. Class A Common Stock
VVNT
$155K 0.11%
22,915
BV icon
160
BrightView Holdings
BV
$1.23B
$150K 0.1%
11,000
TUEM
161
DELISTED
Tuesday Morning Corp
TUEM
$144K 0.1%
4,364
+140
+3% +$6.74K
TTCF
162
PUT
DELISTED
Tattooed Chef, Inc Class A Common Stock
TTCF
$141K 0.1%
+11,200
New +$142K
BHIL
163
DELISTED
Benson Hill, Inc.
BHIL
$120K 0.08%
1,064
SPRY icon
164
ARS Pharmaceuticals
SPRY
$559M
$84K 0.06%
+23,969
New +$104K
DXLG icon
165
Destination XL Group
DXLG
$29.3M
$78K 0.05%
+16,000
New +$77.1K
ALIT icon
166
CALL
Alight
ALIT
$481M
$59K 0.04%
295
CZOO
167
DELISTED
Cazoo Group Ltd
CZOO
$55K 0.04%
10
-8
-44% -$61K
CGTX icon
168
Cognition Therapeutics
CGTX
$82M
$49K 0.03%
17,667
-5,024
-22% -$19.4K
PRQR icon
169
ProQR Therapeutics
PRQR
$251M
$40K 0.03%
43,900
+17,025
+63% +$57K
ADEA icon
170
CALL
Adeia
ADEA
$2.8B
$36K 0.02%
7,938
SIOX
171
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$33K 0.02%
49,528
-10,717
-18% -$9.1K
AON icon
172
Aon
AON
$78.3B
-3,931
Closed -$1.18M
AOUT icon
173
American Outdoor Brands
AOUT
$158M
-22,900
Closed -$456K
ASIX icon
174
AdvanSix
ASIX
$555M
-17,214
Closed -$813K
OPTU
175
Optimum Communications Inc
OPTU
$290M
-12,157
Closed -$197K

Similar funds

Apogem Capital's Q1 2022 Portfolio in Review

As of Q1 2022, Apogem Capital held 210 positions worth $146M, down 4% from $152M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Apogem Capital deployed $6.8M of net new capital in Q1 2022, opening 36 new positions and adding to 52 existing holdings. Its largest new stake was Akoustis Technologies Inc: 314,198 shares worth $2.04M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Fiserv Inc, an estimated $2.19M trimmed.

  • Apogem Capital's largest Q1 2022 buy was Akoustis Technologies Inc: 314,198 shares worth $2.04M.
  • Apogem Capital added most to Orion in Q1 2022, an estimated $3.8M increase.
  • Apogem Capital's biggest Q1 2022 reduction was Fiserv Inc, cutting an estimated $2.19M.
  • Apogem Capital fully exited Ezcorp Inc in Q1 2022, selling an estimated $1.95M.
  • Apogem Capital's ten largest holdings make up 29% of its $146M portfolio in Q1 2022.
  • Apogem Capital opened 36 new positions and closed 36 in Q1 2022.
  • Apogem Capital's portfolio value fell 4% quarter-over-quarter to $146M.

Based on Apogem Capital's 13F filing for Q1 2022, filed 16 May 2022.